Evolutionarily distinct Resistance proteins detect a pathogen effector through its association with different host targets.
Evolutionarily distinct Resistance proteins detect a pathogen effector through its association with different host targets.
复制标题
DOI:
10.1111/nph.17660
复制
发表时间:
2021-08
期刊:
影响因子:
--
通讯作者:
Haixia Wang;F. Trusch;Dionne Turnbull;C. Aguilera-Galvez;Susan Breen;S. Naqvi;Jonathan D. G. Jones;I. Hein;Zhendong Tian;V. Vleeshouwers;Eleanor M. Gilroy;P. Birch
中科院分区:
文献类型:
--
作者:
Haixia Wang;F. Trusch;Dionne Turnbull;C. Aguilera-Galvez;Susan Breen;S. Naqvi;Jonathan D. G. Jones;I. Hein;Zhendong Tian;V. Vleeshouwers;Eleanor M. Gilroy;P. Birch
Critical to durable disease resistance is understanding evolutionary processes governing pathogen recognition. We determined how Phytophthora infestans effector PiAVR2 is recognised by evolutionarily distinct resistance proteins R2 and Rpi-mcq1. We employed yeast-2-hybrid, co-immunoprecipitation, virus-induced gene silencing, transient overexpression, and phosphatase activity assays to investigate contributions of BSL phosphatases to R2- and Rpi-mcq1-mediated hypersensitive response (HR). Silencing PiAVR2 target BSL1 compromises R2 HR. Rpi-mcq1 HR is compromised only when BSL2 and BSL3 are silenced. BSL1 overexpression increases R2 HR and compromises Rpi-mcq1. However, BSL2 or BSL3 overexpression enhance Rpi-mcq1 and compromise R2 HR. Okadaic acid, which inhibits BSL phosphatase activity, suppresses both recognition events. Moreover, expression of a BSL1 phosphatase-dead (PD) mutant suppresses R2 HR, whereas BSL2-PD and BSL3-PD mutants suppresses Rpi-mcq1 HR. R2 interacts with BSL1 in the presence of PiAVR2, but not with BSL2 and BSL3, whereas no interactions were detected between Rpi-mcq1 and BSLs. Thus, BSL1 activity and association with R2 determine recognition of PiAVR2 by R2, whereas BSL2 and BSL3 mediate Rpi-mcq1 perception of PiAVR2. R2 and Rpi-mcq1 utilise distinct mechanisms to detect PiAVR2 based on association with different BSLs, highlighting central roles of these effector targets for both disease and disease resistance.